Stay updated on Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision v3.5.3 was removed. This reflects an update to the page's version history rather than a change to the main content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new version entry, Revision: v3.5.3, was added to the Record History, replacing the previous v3.5.2. This updates the page's revision history to reflect the latest version of the record.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the study record history.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision history updated: added v3.4.3, removed v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision entry v3.4.2 was added to the record history, and the government funding notice along with the v3.4.1 revision entry were removed.SummaryDifference0.8%

Stay in the know with updates to Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.